On Aug 31, 2021 TISSIUM closed a Series C round and raised €50,000,000 from Cathay Capital, Sofinnova Partners, featuring lead investors Cathay Capital.

About the company: TISSIUM is located at France, Europe.
“TISSIUM is creating the future of tissue reconstruction. Learn more about our novel solutions based on our proprietary platform of biomorphic programmable polymers.”

Company website: http://www.tissium.com